Cyberdyne Inc. · TSE:7779
Cyberdyne — FY2015 Earnings Presentation
18 slides from Cyberdyne's earnings presentation, May 15, 2015
Slide 1: Cybernics as human assistive technologies and Future Challenges
CYBERDYNE CYBERDYNE IPO 2015 3 Cybernics as human assistive technologies Cybernics as human assistive technologies and Future Challenges / Shinji UGA 2015 5 15 / CPA CYBERDYNE CFO / Cyberdyne Inc., Director & CFO CYBERDYNE
Slide 2: CYBERDYNE
Qorserorne CYBERDYNE CYBERDYNE
Slide 3: Fiscal 2015 highlights and HAL progress
■ 2015 ■ HAL FDA 2014/11 → 2015 ■ HAL 2015/03 → 2015 ■HAL ( 2014/09, 2015/03 2015/02 ■ (2015/03), (2015 ) ■ 2015 ■ ■Fukushima 2015/05 2015 ■ 414 2014/12 ■ ■CEJ VB/JV CYBERDYNE
Slide 4: CYBERDYNE
© CYBGERDYNE CYBERDYNE
Slide 5: CYBERDYNE
© CYBGERDYNE
Slide 6: CYBERDYNE
© CYBGERDYNE CYBERDYNE
Slide 7: Medical use process for insurance coverage
© CYBGERDYNE edical use Process for insurance coverage Insurance coverage Product Equipment safely test / Clinical safety Approval as a medical device (Applicable laws andreguaons) ODEN test Preparation and documeriaton APplcaon fo — —____- clinical research for application / Ciinical study spprovel
Slide 8: HAL
HAL ʳǖƄʼʴ İèȈij žƞʼʿſƂ^ÍÀ¯³åɵǗŁʘȍÐŰĊúʋßǒʳʘȍɜěßǒʴ_ íȅƦǎƼ Țȧʘȍɢȅķ˄ ɛȘŋɋʐɶɓʁǬȁˍˇˏȚȧʘȍ ÍÀ¯³åɵǗŁķȢ ɋʐɶɓʁǬȁˍˇˏ ʒǴēʓķ ȣÜåě˄ÍÀ¯³ơɗȁd|åěɃºÎѦ¨³ɖe ɛȘŋǗŁ ʒǴēʓŦɁ~Ʈĵ ƇɭǗŁ[n}ˉ˗ˈˋ˓ˊ˗ːˋnjƄïȝ}ʘȍ Ɨ ɖy|jvØȆĔ¥ÀÑ¡ŋÍÀ¯³JÍÀ¯³¨Ñ°ˍ ˇˏKơɗƕȁpv[ɋɶƤʁǬrvÍÀ¯³¨ Ѱ}c\ ʻʴåěɃiɛȘp|ȁd[Ʌʚȯĝô¦¨³rn~}[ ȣÜåěʡɋɶƤ
Slide 9: HAL for well-being
2014 3 26 !!HAL!for!well+being! !(training!use!until!obtaining! medical!approval) CYBERDYNE
Slide 10: Products line-up since 2014
Products!line+up! since!2014 CYBERDYNE
Slide 11: Improved Medical HAL
Improved! Medical!HAL CYBERDYNE
Slide 12: ISO 13482 certification
© CYBGERDYNE t So 4 BAS 2Y HAL (ie AY FA) ISO 13482 ISO 13482 1SO13482 Certificate 1SO13482 Certificate . #OAO MY b CYBERDYNE##S St
Slide 13: CYBERDYNE
© CYBGBERDYNE TERR ! FOVUSEUIZAT ALRIREAGE BAMELE Cc DBMzHHTS saeepORy kb Nf FILE y— CYBERDYNE
Slide 14: News release 2015.05.13
Q orserorne 2015.05.13 BaF sxaes, anus weetan. pana nen) Anan cole [=1-2] 4B Rk. RERRSEHORY MEM ROBRAL~RS RAR - PLPREA TC. REMMRR - BLAERH~ MSRM S MSMR - MAR - RRR BAHS: (2014.1022-31—-2) SAL. Buc RER PSRHORyYb (CHEM MERETSTCCELTHEDET. SEM AOI & Bie RICHES Seo, KE 11 AlCMUBCRABE Re MAM L_(2014.11.18
Slide 15: News release 2014.12.24
CYBEROYNE CYBERDYNE 2014.12.24 Bi [=1-2] ALOVHEOBREAARHMBICOWT CYBERDYNERHA 2 tt (Att : RAG < ST, RRMA: WU, DEYN 94 vy) & ALOVHRARA (Att : RMBARB Th, RRR : URC. WEALOY) i. KA. ORy hBRESOCRAARBEMRLELKOT, BASKWKLET, HAGEL, ALOVSAHO*AY hI-DV-ERAEEBL, VIN-I1 YOHALSSP BREE RY 1 7), HALO REA 947), PEHOMY
Slide 16: CEJ
© CYBGERDYNE — : FOULS BRMAME (BOK E) -_ : ERERED OUKD ERROR Bia FP EAPREB RED eH FE SREY RAMA (CE) AR | BMMBRMPAHOMD AH CYBERDYNE
Slide 17: Clinical studies, FDA application and CE marking
Clinical studies at the Danderyd Hospital of the Karolinska Institute Final application to the FDA in Sweden has been completed was completed in November 2014. Obtaining the approval from the FDA is expected in 2015 CE marking has been obtained in the EU. Therapy using HAL is covered by public worke
Slide 18: CEJ in Haneda Area
CEJ in Haneda Area 大田区 羽田クロノゲート (10ha) H25年9月稼動 <第1ゾーン> (宅地面積:約11ha) 羽田空港周辺の土地利用計画 National!Strategies!in!HANEDA!Airpot!Area Medical!Innovation!Center, ものづくりナノ医療イノベーションセンター(i CON) Zone1! 周辺地域との共生に配慮し、地元の過去の経 Nano!Medicine!Factory (0.8ha)H26年度運営開始予定 緯を踏まえた土地利用を促進 ・東大、東工大、富士フイルム、ニコン等 ●産業交流施設Industrial